← All organizations

Institute of Rheumatology, Belgrade, Serbia

Academic/Hospital

Also known as: University School of Medicine, Dir. Inst. of Rheumatology, Belgrade

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 4, 2019

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

adalimumab

Phase 1 (1 own, 0 via acquisition)

pg-102

Indications

Studied for

Recent trials (2)

NCT04224194Overall official - principal investigatorPhase 3Nov 4, 2019
NCT00787137Overall official - principal investigatorPhase 1Dec 1, 2008

Details

Last known activity: Nov 4, 2019